๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Non-dermatophytes in onychomycosis of the toenails

โœ Scribed by D.H. ELLIS; A.B. WATSON; J.E. MARLEY; T.G. WILLIAMS


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
306 KB
Volume
136
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

โœฆ Synopsis


A multicentre trial for the treatment of dermatophyte onychomycosis of the toenails with terbinafine was carried out in Australia and New Zealand. Between eight and 12 nail samples were obtained from each of the 118 patients in the 48-week trial, and each sample was investigated by direct microscopy and culture for dermatophyte and non-dermatophyte fungi. Patients were randomized to treatment with terbinafine at 250 mg/day or placebo for the first 12 weeks of the study, then non-responders were offered a 12-week course of terbinafine from week 28. All patients had a dermatophyte infection. In 42 patients (36%) microscopy and mycological culture identified dermatophytes alone. In the remaining 76 patients (64%), a non-dermatophyte mould or yeast was also isolated at some stage during the trial, but in only three patients did the same non-dermatophyte persist in two or more successive nail specimens. The presence of a fungal contaminant in addition to a dermatophyte had no apparent effect on the efficacy of treatment with terbinafine. We conclude that non-dermatophyte moulds and yeasts are generally found as contaminating organisms in dermatophyte onychomycosis, secondary to the dermatophytes, and that they do not influence the outcome of treatment.


๐Ÿ“œ SIMILAR VOLUMES


Long-term outcomes in the treatment of t
โœ De Cuyper; B.hindryckx ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB

Most clinical studies in subjects with toenail onychomycosis end with a final assessment at 48-52 weeks. This fails to take full account of the physiology of toenail growth, as toenails can take up to 12-18 months to grow out fully. Accurate assessment of long-term outcomes therefore requires follow

L.I.ON. Study: efficacy and tolerability
โœ Sigurgeirsson; Billstein; Rantanen; Ruzicka; Di Fonzo; Vermeer; Goodfield; Evans ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 415 KB

We undertook a prospective, randomised, double-blind, double-dummy, multicentre, parallel-group study to compare the efficacy and tolerability of continuous terbinafine (Lamisil) with intermittent itraconazole (Sporanox) in the treatment of toenail onychomycosis. A total of 496 patients (age range 1

A randomized trial of amorolfine 5% solu
โœ R. Baran; M. Feuilhade; A. Datry; S. Goettmann; P. Pietrini; C. Viguie; G. Badil ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 298 KB

## Abstract In view of recent advances in the development of antifungal agents, this study examined the possible synergy of two new antifungal agents, terbinafine and amorolfine. The study compared two different courses of terbinafine treatment combined with amorolfine 5% solution nail lacquer. Ter